» Articles » PMID: 17011764

TIM-3 in Autoimmunity

Overview
Publisher Elsevier
Date 2006 Oct 3
PMID 17011764
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

T cell immunoglobulin and mucin domain (TIM)-3 is a molecule expressed on terminally differentiated murine Th1 cells but not on Th2 cells. Identification of galectin-9 as a ligand for TIM-3 has now firmly established the TIM-3-galectin-9 pathway as an important regulator of Th1 immunity and tolerance induction. TIM-3 is similarly expressed on human Th1 cells and not on Th2 cells, which suggests that TIM-3 might also contribute to Th1 regulation in humans. In addition, genetic data associate the TIM locus and specific TIM-3 polymorphisms with various immune-mediated diseases. Most importantly, recent data suggest a novel paradigm in which dysregulation of the TIM-3-galectin-9 pathway could underlie chronic autoimmune disease states, such as multiple sclerosis.

Citing Articles

Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy.

Hu Q, Shi Y, Wang H, Bing L, Xu Z Exp Hematol Oncol. 2025; 14(1):37.

PMID: 40087690 DOI: 10.1186/s40164-025-00627-6.


Immune checkpoints and pancreatic beta cell dysfunction in HIV.

Pryke L, Liu Z, Khaitan A, Sims E, Gupta S AIDS. 2024; 38(11):1725-1727.

PMID: 39088830 PMC: 11296497. DOI: 10.1097/QAD.0000000000003932.


Significant association of elevated serum galectin-9 levels with the development of non-alcoholic fatty liver disease in patients with rheumatoid arthritis.

Chen P, Hsu W, Peng C, Liao T, Chang S, Chen H Front Med (Lausanne). 2024; 11:1347268.

PMID: 38371515 PMC: 10869587. DOI: 10.3389/fmed.2024.1347268.


Recombinant human TIM-3 ectodomain expressed in bacteria and recovered from inclusion bodies as a stable and active molecule.

Lima G, Chura-Chambi R, Morganti L, Silva V, Cabral-Piccin M, Rocha V Front Bioeng Biotechnol. 2023; 11:1227212.

PMID: 37588136 PMC: 10426796. DOI: 10.3389/fbioe.2023.1227212.


Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications.

Das S, Dash B, Premji T, Chen J Int J Mol Sci. 2023; 24(13).

PMID: 37445721 PMC: 10341481. DOI: 10.3390/ijms241310546.